​These days, numerous sophisticated tools are available for discovery and validation of early oncology drugs. These technologies, which include cell lines, patient derived xenograft (PDX) mouse models, biomarker discovery, and ex vivo systems, aim to capture the hetereogeneity of patient disease. Learn about the variety of research tools and technologies that are supporting the development of tomorrow’s oncology therapies. This lunch and learn is hosted by Crown Bioscience.

ZOOM LINK: https://yale.zoom.us/j/94802544606?pwd=Y25Fa3FHcmozRDhOdS9RdDVNYWQrZz09